Why Employer Healthcare Costs Are Rising Faster Than Inflation — and What Employers Must Do Now

On July 10, 1969, President Richard Nixon warned, “We have a massive crisis in this area…without prompt action, we will have a breakdown in our medical care system.” That warning, more than five decades old, rings truer today than ever.  

The United States continues to wrestle with escalating healthcare costs that erode employer budgets, strain employee wallets, and deliver outcomes that lag other developed nations. 

According to CMS National Health Expenditure data, total U.S. health expenditures reached an estimated $5.3 trillion in 2024, or about $15,474 per person, accounting for 18.0% of GDP. While final 2025 totals are not yet published, CMS actuaries project that national health spending will grow by about 7.1% in 2025, reflecting continued robust increases in healthcare utilization and prices. Based on that projected growth rate, total national health expenditures is expected to approach roughly $5.6 trillion in 2025 if the trend holds. Private health insurance, including employer-sponsored plans, remains a major contributor to this growth. 

Healthcare Spending: Still Climbing, Still Unsustainable 

Healthcare spending continues to grow faster than wages and inflation. For employers, this means: 

• Higher annual premium renewals 
• Increased employee contributions 
• Pressure to shift costs through plan design 
• Reduced flexibility in compensation planning 

Employer-sponsored health plans remain the backbone of U.S. coverage, but they are absorbing a disproportionate share of cost growth. Without active cost management, healthcare becomes one of the most volatile and unpredictable line items in the operating budget. 

Prescription Drugs: The Fastest-Growing Component 

Prescription drug spending remains one of the most challenging parts of the U.S. healthcare cost landscape. 

Prescription drug spending now exceeds half a trillion dollars annually, with pharmacy costs accounting for 25%–30% of total healthcare spend in 2024 and projected to continue rising at approximately 6% annually through 2025. Key therapeutic areas are expected to drive prescription plan spend increases of up to 12% in 2026, further accelerating employer cost pressure. 

Federal executive actions aimed at lowering drug costs may influence future employer pharmacy strategies. 

For employer-sponsored health plans: 

• Pharmacy now represents roughly 25%–30% of total healthcare spend 
• Specialty drugs account for a disproportionate share of costs 
• High-cost therapies are expanding into new indications 

Newer weight-loss and diabetic drugs, particularly GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound, are major drivers of this increase. These drugs can cost hundreds to thousands of dollars per patient per month and are expanding beyond diabetes and obesity treatment into other clinical categories, further stretching employer benefit budgets. 

Why GLP-1 Drugs Are Reshaping Employer Budgets 

GLP-1 medications have quickly become one of the most significant pharmacy cost drivers for employer-sponsored health plans. 

While these medications may deliver meaningful clinical outcomes, their rapid adoption raises important employer questions: 

• Should employers cover GLP-1 drugs for weight loss? 
• How should prior authorization be structured? 
• What are the long-term cost implications? 
• How should employers evaluate return on investment for high-cost therapies? 

Without clear benefit design, contract transparency, and vendor oversight, pharmacy trend can outpace overall medical inflation and destabilize plan sustainability. 

What Is Driving Healthcare Cost Growth? 

Several structural factors continue to fuel healthcare inflation: 

• Increased utilization of high-cost specialty drugs 
• Hospital consolidation and provider pricing leverage 
• Expanding chronic disease prevalence 

Rising healthcare costs also intersect with workforce management challenges, including medical leave compliance under federal laws. 

• Technological advancements with premium pricing 
• Administrative complexity across medical and pharmacy systems 

For employers, this creates a dual challenge: maintaining competitive benefits while ensuring long-term financial sustainability. 

Employer Considerations in a High-Cost Environment 

For employers wrestling with these trends, a passive approach to benefit management is no longer viable. 

Financial Sustainability and Benefits Strategy 

Employers must evaluate whether current plan structures align with long-term budget forecasting. Multi-year modeling and actuarial review are critical. 

Employers should also evaluate tax credits and deduction opportunities tied to federal healthcare legislation. 

Pharmacy Spend Visibility and Accountability 

Many employers lack full transparency into pharmacy benefit manager (PBM) contracts, rebate structures, and pricing models. Greater visibility is essential for effective cost containment. 

Smart Benefit Design and Affordability 

Employers may consider: 

• Tiered formularies 
• Value-based plan design 
• Reference-based pricing 
• Centers of Excellence Programs 
• High-performance networks 

Exploring Alternative PBM and Cost Models 

Traditional PBM arrangements may not align incentives around cost control. Alternative contracting models and transparent PBM strategies are gaining traction among mid-size and large employers. 

Regulatory Compliance and Oversight 

Healthcare cost containment must align with: 

• ACA affordability requirements 

Employers must also evaluate potential exposure under ACA employer mandate penalties, including Pay or Play provisions. 

• ERISA fiduciary responsibilities 
• Mental Health Parity compliance 
• Nondiscrimination rules 

Cost control strategies must balance financial objectives with compliance obligations. 

Employee Engagement and Education 

Employee behavior directly impacts healthcare spending. Employers who invest in education around plan utilization, preventive care, and medication management often see better cost outcomes over time. 

Frequently Asked Employer Questions 

1. Why are employer healthcare costs rising faster than inflation? 
   Medical trend, specialty drugs, provider pricing leverage, and regulatory complexity all contribute to sustained cost growth above general inflation. 
2. Are GLP-1 medications the primary driver of pharmacy trend? 
   GLP-1 medications are a major emerging cost driver, but specialty drugs across oncology, autoimmune, and rare disease categories also significantly impact spend. 
3. What can employers do to control pharmacy costs? 
   Employers can evaluate PBM contracts, review formulary management strategies, implement prior authorization controls, and explore alternative funding or cost-sharing models. 

Looking Ahead 

Legislative changes continue to reshape the benefits landscape, including major federal reform efforts impacting employer-sponsored coverage. 

The cost crisis that was warned about decades ago has not gone away. It has evolved. 

Healthcare spending continues to grow faster than incomes and GDP, burdening employers, employees, and the broader economy alike. The future of American healthcare depends on innovative cost containment strategies that safeguard both affordability and quality of care. 

Employers that proactively assess risk, evaluate vendor performance, and implement structured cost containment strategies will be better positioned to sustain competitive benefits without sacrificing financial stability. 

Take Control of Your Healthcare Spend Before It Controls Your Business 

If rising healthcare costs, pharmacy trend, and GLP-1 utilization are straining your benefit budget, now is the time for a strategic review. 

Schedule a Healthcare Cost Containment Assessment to: 

• Analyze pharmacy spend drivers 
• Evaluate PBM transparency and pricing structures 
• Model long-term cost projections 
• Identify immediate and long-term savings opportunities 
• Ensure compliance alignment with ACA and ERISA obligations 

Talk to an expert on our Employee Benefits advisory team today to build a sustainable, data-driven healthcare cost strategy.